Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · IEX Real-Time Price · USD
8.45
+0.65 (8.33%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Cryo-Cell International Revenue

Cryo-Cell International had revenue of $31.37M in the twelve months ending February 29, 2024, with 1.52% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $7.85M with 0.36% year-over-year growth. In the fiscal year ending November 30, 2023, Cryo-Cell International had annual revenue of $31.34M with 3.32% growth.

Revenue (ttm)
$31.37M
Revenue Growth
+1.52%
P/S Ratio
2.18
Revenue / Employee
$382,579
Employees
82
Market Cap
68.48M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202331.34M1.01M3.32%
Nov 30, 202230.34M1.45M5.03%
Nov 30, 202128.88M-2.26M-7.26%
Nov 30, 202031.15M-668.98K-2.10%
Nov 30, 201931.82M2.60M8.89%
Nov 30, 201829.22M3.83M15.10%
Nov 30, 201725.38M2.26M9.76%
Nov 30, 201623.13M2.04M9.66%
Nov 30, 201521.09M964.89K4.79%
Nov 30, 201420.13M1.13M5.96%
Nov 30, 201318.99M1.02M5.70%
Nov 30, 201217.97M51.59K0.29%
Nov 30, 201117.92M155.58K0.88%
Nov 30, 201017.76M104.46K0.59%
Nov 30, 200917.66M380.18K2.20%
Nov 30, 200817.28M-182.14K-1.04%
Nov 30, 200717.46M279.81K1.63%
Nov 30, 200617.18M2.73M18.88%
Nov 30, 200514.45M2.24M18.35%
Nov 30, 200412.21M4.66M61.74%
Nov 30, 20037.55M855.76K12.78%
Nov 30, 20026.69M2.18M48.24%
Nov 30, 20014.52M2.41M114.07%
Nov 30, 20002.11M408.36K24.01%
Nov 30, 19991.70M1.37M413.68%
Nov 30, 1998331.13K-86.78K-20.76%
Nov 30, 1997417.91K-2.25M-84.35%
Nov 30, 19962.67M2.17M433.92%
Nov 30, 1995500.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Personalis 73.48M
Turnstone Biologics 19.31M
Celularity 14.79M
CollPlant Biotechnologies 10.96M
Asensus Surgical 8.58M
Cue Biopharma 5.49M
Revenue Rankings